Esperion Therapeutics (ESPR) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist

1.700
+0.040+2.41%

Close Feb 28 16:00 ET

1.710
+0.010+0.59%

Post 20:01 ET

334.96MMarket Cap-2.54P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Esperion Therapeutics, Inc. (ESPR) the Best Small Cap Pharma Stocks to Buy Now?
Yahoo FinanceMar 1 07:24 ET
Earnings Preview: ESPR to Report Financial Results Pre-market on March 04
Moomoo NewsFeb 26 20:00 ET
Will Esperion Therapeutics (ESPR) Report Negative Earnings Next Week? What You Should Know
Zacks Feb 25 09:10 ET
Esperion to Report Fourth Quarter and Full Year 2024 Financial Results on March 4
GlobeNewswireFeb 18 08:00 ET
Express News | Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersFeb 13 16:30 ET
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswireFeb 13 16:30 ET

Comments

Tonyco

Feb 26 15:36

$Esperion Therapeutics (ESPR.US)$
Probably gonna close this position too.
25% Canadian tariff exposes ESPR to $12-15M cost increase annually.
Pivot to India for supply, unfortunately Novo Nordisk and other giants did too, resulting in a 14-18M backlog. This will delay their shift to at least 2026, so that's at least 1 year of exposure.
58% Dependence on Medicare funds.

CH16

Feb 26 08:35

$Esperion Therapeutics (ESPR.US)$ Anyone else saw the $1.9 pre market trade?

10xStockPicks

Feb 26 00:30

Analysts Internal Bullish Notes 2/26/2025

$Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics On The Verge Of Being Acquired, Upside Could Be Over 500% In The Near Future
$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): An Acquisition Candidate High-Growth Opportunity with Potential 10x Returns. I highly recommend you buy a little for an investment while the stock price is ridiculously undervalued.
Latest analyst note: In simple terms, doctors are now prescribing Nexletol (both...

104364940

Feb 25 08:28

$Esperion Therapeutics (ESPR.US)$ up...

10xStockPicks

Feb 21 07:57

Esperion Therapeutics On The Verge Of Being Acquired, Upside Could Be Over 500% In The Near Future

$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): A High-Growth Opportunity with Potential 10x Returns
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...

ESPR Esperion Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks